CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug put nerve disease into Long-Term remission?
Disease control TerminatedThis study aimed to test if rituximab, a drug that targets immune B cells, could help control Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a disorder where the immune system attacks the nerves. Researchers wanted to see if the drug could allow some patients to stop t…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Researchers track Long-Term safety of promising nerve disorder treatment
Disease control ENROLLING_BY_INVITATIONThis study follows up on a previous trial to check the long-term safety of batoclimab, an investigational treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). About 108 adults who completed the earlier study will receive weekly injections for up to one year. Th…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
One Patient's own stem cells tested against debilitating nerve condition
Disease control NO_LONGER_AVAILABLEThis program provided special access to an experimental treatment for one patient with chronic inflammatory demyelinating polyneuropathy (CIDP), a condition where the immune system attacks the nerves. Doctors tested whether infusions of the patient's own previously stored stem ce…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Immune system 'Reset' tested for devastating brain and nerve diseases
Disease control OngoingThis study is testing a high-dose chemotherapy and stem cell transplant procedure for people with severe autoimmune diseases that attack the brain, spinal cord, or nerves, and who haven't responded to standard treatments. The goal is to 'reset' the patient's immune system to stop…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New shot could replace IV drips for nerve disease
Disease control OngoingThis study is testing if adults with a chronic nerve disease called CIDP can safely switch from their current intravenous (IV) treatment to a newer medication given as a shot under the skin. The goal is to see if patients can successfully make the switch and continue the new trea…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE4 • Sponsor: argenx • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New test aims to stop dangerous falls for people with Muscle-Weakening diseases
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create and validate a simple set of physical tests to better predict the risk of falling for people with various nerve and muscle disorders. Researchers will test 108 patients with conditions like muscular dystrophy and ALS using tasks like standing up from a c…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC